Back

Primary endpoint is negative, what next? A clinical perspective.

29 August 2016 (08:30 - 08:52)
Organised by:
Congress Presentation Part of: Interpreting clinical trials: does a primary endpoint tell it all? Drug therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Marc Pfeffer

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail
Primary endpoint is negative, what next? A statistical perspective.
Professor S. Pocock (London, GB)
Slides Video
Presentation thumbnail
Primary endpoint is positive, is that enough? A clinical perspective.
Doctor G. Stone (New York City, US)
Slides Video
Presentation thumbnail
Primary endpoint is positive, is that enough? A statistical perspective.
Professor P. Juni (Oxford, GB)
Slides Video

Access the full session

Session thumbnail
Interpreting clinical trials: does a primary endpoint tell it all?

The Event

Event poster

ESC Congress 2016

29 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Meaningful endpoints in cardiovascular outcome trials.
27 August 2022
thumbnail
Congress Presentation
Study design, result reporting and publication of late-stage cardiovascular trials
28 August 2020
thumbnail
Congress Presentation
Biomarker-guided early heart failure assessment in hospitalized patients with tachypnea: results from the Akershus Cardiac Examination 4 Study
29 August 2026
thumbnail
Congress Presentation
Risks and benefits of antiplatelet therapy in patients with abdominal aortic aneurysm without symptomatic atherosclerotic disease: a nationwide cohort study
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources